Variant report
Variant | nsv968869 |
---|---|
Chromosome Location | chr5:5390492-5394978 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs575764617 | chr5:5390511-5390512 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs113384633 | chr5:5390512-5390513 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs140866622 | chr5:5390518-5390519 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs373848976 | chr5:5390522-5390523 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs564490388 | chr5:5390576-5390577 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs150243295 | chr5:5390581-5390582 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs540565875 | chr5:5390589-5390590 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs56254656 | chr5:5390603-5390604 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs11134113 | chr5:5390680-5390681 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs528081897 | chr5:5390696-5390697 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs541375718 | chr5:5390728-5390729 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs561467873 | chr5:5390730-5390731 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs530487445 | chr5:5390737-5390738 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs550784525 | chr5:5390773-5390774 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs570531715 | chr5:5390784-5390785 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs533306552 | chr5:5390796-5390797 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs546569268 | chr5:5390798-5390799 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs55639718 | chr5:5390804-5390805 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs143097573 | chr5:5390807-5390808 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs375257408 | chr5:5390850-5390851 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs555773257 | chr5:5390928-5390929 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs569391457 | chr5:5390937-5390938 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs186757561 | chr5:5390970-5390971 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs558374921 | chr5:5390975-5390976 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs11134114 | chr5:5390992-5390993 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs540778026 | chr5:5391053-5391054 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs192117211 | chr5:5391074-5391075 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs10475297 | chr5:5391099-5391100 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs541439402 | chr5:5391183-5391184 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs530354459 | chr5:5391184-5391185 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs184053065 | chr5:5391192-5391193 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs530546423 | chr5:5391212-5391213 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs543970286 | chr5:5391229-5391230 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs9313110 | chr5:5391231-5391232 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs532991542 | chr5:5391259-5391260 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs186638435 | chr5:5391265-5391266 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs189819237 | chr5:5391278-5391279 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs566797526 | chr5:5391295-5391296 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs529170279 | chr5:5391298-5391299 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs549435371 | chr5:5391305-5391306 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs548883573 | chr5:5391361-5391362 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs569254537 | chr5:5391384-5391385 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs538374809 | chr5:5391445-5391446 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs182474966 | chr5:5391460-5391461 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs571665019 | chr5:5391487-5391488 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs186881171 | chr5:5391563-5391564 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs371721078 | chr5:5391641-5391642 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs553914071 | chr5:5391656-5391657 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs116277341 | chr5:5391671-5391672 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs542890944 | chr5:5391680-5391681 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 22286061 | CNVD |
Lung cancer | 21911935 | CNVD |
Cri-du chat syndrome | 21549014 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
renal disease | 17924346 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Developmental delay | 21147756 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Melanoma | 22183965 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Schizophrenia | 23813976 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:5381000-5394400 | Weak transcription | Brain Hippocampus Middle | brain |
2 | chr5:5389200-5399400 | Weak transcription | Aorta | Aorta |
3 | chr5:5390200-5390800 | Enhancers | Adipose Nuclei | Adipose |
4 | chr5:5390200-5391800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr5:5390400-5390600 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr5:5390600-5390800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr5:5390800-5391000 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr5:5390800-5391200 | Enhancers | Placenta | Placenta |
9 | chr5:5390800-5391400 | Weak transcription | Adipose Nuclei | Adipose |
10 | chr5:5391000-5391600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
11 | chr5:5391400-5391600 | Enhancers | Adipose Nuclei | Adipose |
12 | chr5:5391800-5394800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
13 | chr5:5392800-5393200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
14 | chr5:5393000-5393200 | Enhancers | Placenta | Placenta |
15 | chr5:5393000-5393400 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
16 | chr5:5394600-5394800 | Enhancers | Pancreas | Pancrea |
17 | chr5:5394800-5395000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
18 | chr5:5394800-5399600 | Weak transcription | Pancreas | Pancrea |